Efficacy of initial triple combination therapy with metformin, dapagliflozin and saxagliptin in drug-naive patients with type 2 diabetes: a randomised controlled trial

被引：0
|
作者：
Kim, N. [1 ]
Kim, J. [2 ]
Moon, J. [3 ]
Lee, Y. -H. [4 ]
Kim, T. [5 ]
Cho, H. [6 ]
Kwak, S. [7 ]
Lim, S. [8 ]
Kim, D. [9 ]
Moon, M. [10 ]
Kim, S. [11 ]
机构：
[1] Korea Univ, Internal Med, Coll Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[3] Yeungnam Univ, Coll Med, Daegu, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Seoul Med Ctr, Seoul, South Korea
[6] Keimyung Univ, Sch Med, Deagu, South Korea
[7] Seoul Natl Univ Hosp, Seoul, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[9] Konkuk Univ, Coll Med, Seoul, South Korea
[10] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
[11] Korea Univ, Coll Med, Seoul, South Korea
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
285
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Mu, Yiming
    Pan, Changyu
    Fan, Bei
    Hehnke, Uwe
    Zhang, Xiuzhen
    Zhang, Xuejun
    Wang, Xiaoyue
    Liu, Jingdong
    Zhang, Ying
    Du, Jianling
    Ma, Jianhua
    Gong, Yan
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 48 - 56
  • [12] Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naive Patients With Type 2 Diabetes
    Rosenstock, Julio
    Inzucchi, Silvio E.
    Seufert, Jochen
    Fleck, Penny R.
    Wilson, Craig A.
    Mekki, Qais
    [J]. DIABETES CARE, 2010, 33 (11) : 2406 - 2408
  • [13] Comparative efficacy of saxagliptin combination therapy with acarbose, or gliclazide modified release, or metformin in drug naive patients with type 2 diabetes
    Chen, X. P.
    Li, H. M.
    Kuang, H. Y.
    Chen, L.
    Ma, J. H.
    Zhang, Q.
    Pan, T. R.
    He, J.
    Yang, W. Y.
    [J]. DIABETOLOGIA, 2018, 61 : S377 - S377
  • [14] Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
    Henry, R. R.
    Murray, A. V.
    Marmolejo, M. H.
    Hennicken, D.
    Ptaszynska, A.
    List, J. F.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (05) : 446 - 456
  • [15] Efficacy and Safety of Saxagliptin plus Metformin as Initial Therapy in Patients with Type 2 Diabetes
    Dou, Jingtao
    Ma, Jianhua
    Liu, Jun
    Wang, Changjiang
    Johnsson, Eva
    Yao, Yolanda
    Zhao, June
    Pan, Changyu
    [J]. DIABETES, 2017, 66 : A327 - A327
  • [16] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [17] Efficacy and safety of saxagliptin and metformin as initial combination therapy in patients with type 2 diabetes: a meta-analysis
    Tan, Xue-Ying
    Lu, Yang
    Xuan, Li-Ping
    Huang, Yong-Min
    Hu, Jing-Bo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 18816 - 18823
  • [18] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
  • [19] Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes
    Rosenstock, Julio
    Chuck, Leonard
    Gonzalez-Ortiz, Manuel
    Merton, Kate
    Craig, Jagriti
    Capuano, George
    Qiu, Rong
    [J]. DIABETES CARE, 2016, 39 (03) : 353 - 362
  • [20] Effects of gemigliptin versus sitagliptin or glimepiride on glycaemic variability as initial combination therapy with metformin in drug-naive patients with type 2 diabetes
    Lee, B. -W.
    Kim, J.
    Park, S.
    Jung, C.
    Lee, S. -H.
    Suh, S.
    Lee, W.
    Cho, J. -H.
    Jang, Y.
    Kim, S. -H.
    Park, C. -Y.
    [J]. DIABETOLOGIA, 2015, 58 : S387 - S387
12345